{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:15:22Z","timestamp":1648581322462},"reference-count":13,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jad.2010.01.007","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T09:18:35Z","timestamp":1265361515000},"page":"184-188","source":"Crossref","is-referenced-by-count":1,"title":["Benzodiazepine and cyclopyrrolone reduction in general practice \u2014 Does this lead to change in the use of antidepressants? A study based on a Danish population"],"prefix":"10.1016","volume":"125","author":[{"given":"Viggo Rask Kragh","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2010.01.007_bib1","unstructured":"Addictive drugs. Prescription and justification [in Norwegian]. Norwegian Board of Health. http:\/\/www.helsetilsynet.no\/upload\/publikasjoner\/andrepublikasjoner\/vanedannende_legemidler_forskrivning_forsvarlighet_ik-2755.pdf [Accessed 2009 Sep 27]."},{"key":"10.1016\/j.jad.2010.01.007_bib2","series-title":"Benzodiazepines Warning, Chief Medical Officer's Update 37, Patient Safety","year":"2004"},{"key":"10.1016\/j.jad.2010.01.007_bib3","series-title":"Communication Regarding the Prescription of Addictive Drugs","year":"2008"},{"issue":"11","key":"10.1016\/j.jad.2010.01.007_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2165\/00023210-200721110-00006","article-title":"An approach to reduce benzodiazepine and cyclopyrrolone use in general practice, a study based on a Danish population","volume":"21","author":"J\u00f8rgensen","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2010.01.007_bib5","first-page":"16","article-title":"Benzodiazepine and cyclopyrrolone reduction in practice: a study by a Danish municipality","volume":"9","author":"J\u00f8rgensen","year":"2007","journal-title":"L\u00e6ge Magasinet"},{"key":"10.1016\/j.jad.2010.01.007_bib6","series-title":"Can the Consumption of Benzodiazepines and Cyclopyrrolones be Reduced in General Practice?","author":"J\u00f8rgensen","year":"2009"},{"key":"10.1016\/j.jad.2010.01.007_bib7","first-page":"2999","article-title":"Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices","volume":"171","author":"J\u00f8rgensen","year":"2009","journal-title":"Ugeskr. Laeger"},{"issue":"3","key":"10.1016\/j.jad.2010.01.007_bib8","first-page":"136","article-title":"Reduction in the use of benzodiazepines and cyclopyrrolones in general practice","volume":"6","author":"J\u00f8rgensen","year":"2008","journal-title":"Pharm. Pract."},{"key":"10.1016\/j.jad.2010.01.007_bib9","first-page":"12","article-title":"Intervention against the excessive use of benzodiazepines and cyclopyrrolones in general practice","volume":"9","author":"J\u00f8rgensen","year":"2008","journal-title":"L\u00e6ge Magasinet"},{"key":"10.1016\/j.jad.2010.01.007_bib10","first-page":"1636","article-title":"Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice!","volume":"168","author":"J\u00f8rgensen","year":"2006","journal-title":"Ugeskr. Laeger"},{"issue":"2","key":"10.1016\/j.jad.2010.01.007_bib11","first-page":"74","article-title":"Reducing the use of benzodiazepines and cyclopyrrolones in clinical practices","volume":"4","author":"J\u00f8rgensen","year":"2006","journal-title":"Pharm. Pract."},{"key":"10.1016\/j.jad.2010.01.007_bib12","series-title":"Reference Listings for Anxiety Disorders in Adults","year":"2007"},{"issue":"17","key":"10.1016\/j.jad.2010.01.007_bib13","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.1991.03470170080028","article-title":"Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations","volume":"266","author":"Weintraub","year":"1991","journal-title":"JAMA"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032710000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032710000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T12:27:17Z","timestamp":1544704037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032710000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":13,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0165032710000339"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2010.01.007","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}